| Year |
Citation |
Score |
| 2021 |
Hongo D, Zheng P, Dutt S, Pawar RD, Meyer E, Engleman EG, Strober S. Identification of Two Subsets of Murine DC1 Dendritic Cells That Differ by Surface Phenotype, Gene Expression, and Function. Frontiers in Immunology. 12: 746469. PMID 34777358 DOI: 10.3389/fimmu.2021.746469 |
0.346 |
|
| 2021 |
Ouyang X, Liu Y, Zhou Y, Guo J, Wei TT, Liu C, Lee B, Chen B, Zhang A, Casey KM, Wang L, Kooreman NG, Habtezion A, Engleman EG, Wu JC. Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. Stem Cell Reports. PMID 33961792 DOI: 10.1016/j.stemcr.2021.04.004 |
0.529 |
|
| 2020 |
Marshall PL, Nagy N, Kaber G, Barlow GL, Ramesh A, Xie BJ, Linde MH, Haddock NL, Lester CA, Tran QL, de Vries C, Hargil A, Malkovskiy A, Gurevich I, Martinez HA, ... ... Engleman EG, et al. Hyaluronan synthesis inhibition impairs antigen presentation and delays transplantation rejection. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 33290836 DOI: 10.1016/j.matbio.2020.12.001 |
0.328 |
|
| 2020 |
Zhang X, Zheng P, Prestwood TR, Zhang H, Carmi Y, Tolentino LL, Wu N, Choi O, Winer DA, Strober S, Kang ES, Alonso MN, Engleman EG. Human Regulatory Dendritic Cells Develop From Monocytes in Response to Signals From Regulatory and Helper T Cells. Frontiers in Immunology. 11: 1982. PMID 32973804 DOI: 10.3389/Fimmu.2020.01982 |
0.34 |
|
| 2019 |
Tsai HC, Nguyen K, Hashemi E, Engleman E, Hla T, Han MH. Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation. Journal of Autoimmunity. PMID 31202617 DOI: 10.1016/J.Jaut.2019.06.001 |
0.376 |
|
| 2018 |
Dutt S, Atallah MB, Minamida Y, Filatenkov A, Jensen KP, Iliopoulou BP, Tamosiuniene R, Waters J, Engleman EG, Strober S. Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell-mediated remissions. Blood Advances. 2: 2568-2580. PMID 30301812 DOI: 10.1182/Bloodadvances.2018023119 |
0.351 |
|
| 2018 |
Tsai S, Clemente-Casares X, Zhou AC, Lei H, Ahn JJ, Chan YT, Choi O, Luck H, Woo M, Dunn SE, Engleman EG, Watts TH, Winer S, Winer DA. Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection. Cell Metabolism. PMID 30174303 DOI: 10.1016/J.Cmet.2018.08.003 |
0.319 |
|
| 2017 |
Kenkel JA, Tseng WW, Davidson MG, Tolentino L, Choi O, Bhattacharya N, Seeley ES, Winer D, Reticker-Flynn NE, Engleman EG. An immunosuppressive dendritic cell subset accumulates at secondary sites and promotes metastasis in pancreatic cancer. Cancer Research. PMID 28611041 DOI: 10.1158/0008-5472.CAN-16-2212 |
0.366 |
|
| 2017 |
Ghazarian M, Revelo XS, Nøhr MK, Luck H, Zeng K, Lei H, Tsai S, Schroer SA, Park YJ, Chng MHY, Shen L, D'Angelo JA, Horton P, Chapman WC, Brockmeier D, ... ... Engleman EG, et al. Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome. Science Immunology. 2. PMID 28567448 DOI: 10.1126/Sciimmunol.Aai7616 |
0.311 |
|
| 2017 |
Hongo D, Tang X, Zhang X, Engleman EG, Strober S. Tolerogenic interactions between CD8+ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts. Blood. PMID 28096089 DOI: 10.1182/Blood-2016-07-723015 |
0.372 |
|
| 2017 |
McLaughlin T, Ackerman SE, Shen L, Engleman E. Role of innate and adaptive immunity in obesity-associated metabolic disease. The Journal of Clinical Investigation. 127: 5-13. PMID 28045397 DOI: 10.1172/Jci88876 |
0.431 |
|
| 2015 |
Carmi Y, Spitzer MH, Linde IL, Burt BM, Prestwood TR, Perlman N, Davidson MG, Kenkel JA, Segal E, Pusapati GV, Bhattacharya N, Engleman EG. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 521: 99-104. PMID 25924063 DOI: 10.1038/nature14424 |
0.329 |
|
| 2015 |
Shen L, Zhang H, Caimol M, Benike CJ, Chakravarty EF, Strober S, Engleman EG. Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production. European Journal of Immunology. 45: 612-23. PMID 25352488 DOI: 10.1002/Eji.201444760 |
0.321 |
|
| 2014 |
McLaughlin T, Liu LF, Lamendola C, Shen L, Morton J, Rivas H, Winer D, Tolentino L, Choi O, Zhang H, Hui Yen Chng M, Engleman E. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 2637-43. PMID 25341798 DOI: 10.1161/Atvbaha.114.304636 |
0.38 |
|
| 2014 |
Hongo D, Tang X, Baker J, Engleman EG, Strober S. Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 14: 2467-77. PMID 25311657 DOI: 10.1111/Ajt.12914 |
0.378 |
|
| 2014 |
Riess JW, Bhattacharya N, Blenman KR, Neal JW, Hwang G, Pultar P, San-Pedro Salcedo M, Engleman E, Lee PP, Malik R, Wakelee HA. Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients. Immunopharmacology and Immunotoxicology. 36: 182-6. PMID 24494587 DOI: 10.3109/08923973.2013.864671 |
0.342 |
|
| 2013 |
Davidson MG, Alonso MN, Kenkel JA, Suhoski MM, González JC, Yuan R, Engleman EG. In vivo T cell activation induces the formation of CD209(+) PDL-2(+) dendritic cells. Plos One. 8: e76258. PMID 24098455 DOI: 10.1371/Journal.Pone.0076258 |
0.383 |
|
| 2012 |
Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Sarwal M, Millan MT, Shizuru JA, Lowsky R, Engleman EG, Strober S. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 12: 1133-45. PMID 22405058 DOI: 10.1111/J.1600-6143.2012.03992.X |
0.315 |
|
| 2011 |
Scandling JD, Busque S, Shizuru JA, Engleman EG, Strober S. Induced immune tolerance for kidney transplantation. The New England Journal of Medicine. 365: 1359-60. PMID 21991976 DOI: 10.1056/Nejmc1107841 |
0.331 |
|
| 2011 |
Alonso MN, Wong MT, Zhang AL, Winer D, Suhoski MM, Tolentino LL, Gaitan J, Davidson MG, Kung TH, Galel DM, Nadeau KC, Kim J, Utz PJ, Söderström K, Engleman EG. T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets. Blood. 118: 3311-20. PMID 21813450 DOI: 10.1182/Blood-2011-03-341065 |
0.545 |
|
| 2009 |
Winer S, Paltser G, Chan Y, Tsui H, Engleman E, Winer D, Dosch HM. Obesity predisposes to Th17 bias. European Journal of Immunology. 39: 2629-35. PMID 19662632 DOI: 10.1002/Eji.200838893 |
0.325 |
|
| 2009 |
Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, Maezawa Y, Drucker DJ, Engleman E, Winer D, Dosch HM. Normalization of obesity-associated insulin resistance through immunotherapy. Nature Medicine. 15: 921-9. PMID 19633657 DOI: 10.1038/Nm.2001 |
0.45 |
|
| 2009 |
Dejbakhsh-Jones S, Scandling J, Busque S, Nador R, Hongo D, Benike C, Mukhopadhyay A, Engleman E, Strober S. OR.73. Changes in T Cells Subsets in Humans with Tolerance and Chimerism after Renaland Hematopoietic Cell Transplantation Clinical Immunology. 131: S30. DOI: 10.1016/J.Clim.2009.03.085 |
0.409 |
|
| 2008 |
Björck P, Beilhack A, Herman EI, Negrin RS, Engleman EG. Plasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivo. Journal of Immunology (Baltimore, Md. : 1950). 181: 3811-7. PMID 18768834 |
0.331 |
|
| 2007 |
Tseng W, Leong X, Engleman E. Orthotopic mouse model of colorectal cancer. Journal of Visualized Experiments : Jove. 484. PMID 18989400 DOI: 10.3791/484 |
0.301 |
|
| 2007 |
Colmenero P, Zhang AL, Qian T, Lu L, Cantor H, Söderström K, Engleman EG. Qa-1(b)-dependent modulation of dendritic cell and NK cell cross-talk in vivo. Journal of Immunology (Baltimore, Md. : 1950). 179: 4608-15. PMID 17878358 DOI: 10.4049/Jimmunol.179.7.4608 |
0.546 |
|
| 2007 |
Mende I, Engleman EG. Breaking self-tolerance to tumor-associated antigens by in vivo manipulation of dendritic cells. Methods in Molecular Biology (Clifton, N.J.). 380: 457-68. PMID 17876112 DOI: 10.1007/978-1-59745-395-0_29 |
0.323 |
|
| 2007 |
Fernandez I, Zeiser R, Karsunky H, Kambham N, Beilhack A, Soderstrom K, Negrin RS, Engleman E. CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 179: 2808-14. PMID 17709494 DOI: 10.4049/Jimmunol.179.5.2808 |
0.414 |
|
| 2007 |
Zhang AL, Colmenero P, Purath U, Teixeira de Matos C, Hueber W, Klareskog L, Tarner IH, Engleman EG, Söderström K. Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood. 110: 2484-93. PMID 17626840 DOI: 10.1182/Blood-2007-02-076364 |
0.577 |
|
| 2007 |
Standley SM, Mende I, Goh SL, Kwon YJ, Beaudette TT, Engleman EG, Fréchet JM. Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity. Bioconjugate Chemistry. 18: 77-83. PMID 17226959 DOI: 10.1021/Bc060165I |
0.308 |
|
| 2005 |
Mende I, Engleman EG. Breaking tolerance to tumors with dendritic cell-based immunotherapy. Annals of the New York Academy of Sciences. 1058: 96-104. PMID 16394129 DOI: 10.1196/annals.1359.018 |
0.352 |
|
| 2004 |
Engleman EG, Brody J, Soares L. Using signaling pathways to overcome immune tolerance to tumors. Science's Stke : Signal Transduction Knowledge Environment. 2004: pe28. PMID 15252217 DOI: 10.1126/stke.2412004pe28 |
0.32 |
|
| 2004 |
Merad M, Hoffmann P, Ranheim E, Slaymaker S, Manz MG, Lira SA, Charo I, Cook DN, Weissman IL, Strober S, Engleman EG. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nature Medicine. 10: 510-7. PMID 15098028 DOI: 10.1038/Nm1038 |
0.317 |
|
| 2004 |
Soares L, Seroogy C, Skrenta H, Anandasabapathy N, Lovelace P, Chung CD, Engleman E, Fathman CG. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nature Immunology. 5: 45-54. PMID 14661020 DOI: 10.1038/Ni1017 |
0.46 |
|
| 2003 |
Engleman EG. Dendritic cell-based cancer immunotherapy. Seminars in Oncology. 30: 23-9. PMID 12881809 |
0.334 |
|
| 2002 |
Merad M, Sugie T, Engleman EG, Fong L. In vivo manipulation of dendritic cells to induce therapeutic immunity. Blood. 99: 1676-82. PMID 11861283 DOI: 10.1182/Blood.V99.5.1676 |
0.369 |
|
| 2001 |
Fong L, Hou Y, Rivas A, Benike C, Yuen A, Fisher GA, Davis MM, Engleman EG. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proceedings of the National Academy of Sciences of the United States of America. 98: 8809-14. PMID 11427731 DOI: 10.1073/Pnas.141226398 |
0.375 |
|
| 2001 |
Fong L, Brockstedt D, Benike C, Wu L, Engleman EG. Dendritic cells injected via different routes induce immunity in cancer patients. Journal of Immunology (Baltimore, Md. : 1950). 166: 4254-9. PMID 11238679 DOI: 10.4049/jimmunol.166.6.4254 |
0.331 |
|
| 2000 |
Shapero MH, Kundu SK, Engleman E, Laus R, Van Schooten WCA, Merigan TC. In Vivo Persistence of Donor Cells following Adoptive Transfer of Allogeneic Dendritic Cells in HIV-Infected Patients. Cell Transplantation. 9: 307-317. PMID 28880658 DOI: 10.1177/096368970000900302 |
0.38 |
|
| 2000 |
Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Annual Review of Immunology. 18: 245-73. PMID 10837059 DOI: 10.1146/annurev.immunol.18.1.245 |
0.305 |
|
| 2000 |
Merad M, Fong L, Bogenberger J, Engleman EG. Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo Blood. 96: 1865-1872. DOI: 10.1182/blood.V96.5.1865.h8001865_1865_1872 |
0.362 |
|
| 2000 |
Merad M, Fong L, Bogenberger J, Engleman EG. Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo Blood. 96: 1865-1872. DOI: 10.1182/Blood.V96.5.1865.H8001865_1865_1872 |
0.362 |
|
| 1998 |
Jenkins DE, Yasukawa LL, Benike CJ, Engleman EG, Arvin AM. Isolation and utilization of human dendritic cells from peripheral blood to assay an in vitro primary immune response to varicella-zoster virus peptides. The Journal of Infectious Diseases. 178: S39-42. PMID 9852971 DOI: 10.1086/514258 |
0.325 |
|
| 1998 |
Kundu SK, Engleman E, Benike C, Shapero MH, Dupuis M, van Schooten WC, Eibl M, Merigan TC. A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients. Aids Research and Human Retroviruses. 14: 551-60. PMID 9591709 DOI: 10.1089/Aid.1998.14.551 |
0.412 |
|
| 1998 |
Peshwa MV, Benike C, Dupuis M, Kundu SK, Engleman EG, Merigan TC, van Schooten WC. Generation of primary peptide-specific CD8+ cytotoxic T-lymphocytes in vitro using allogeneic dendritic cells. Cell Transplantation. 7: 1-9. PMID 9489758 DOI: 10.1016/S0963-6897(97)00004-3 |
0.333 |
|
| 1998 |
Engleman EG. Dendritic cells: potential role in cancer therapy. Cytotechnology. 25: 1-8. PMID 9474803 DOI: 10.1023/A:1007997918593 |
0.383 |
|
| 1997 |
Soares LR, Rivas A, Ruegg C, Engleman EG. Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen. European Journal of Immunology. 27: 1413-21. PMID 9209493 DOI: 10.1002/eji.1830270618 |
0.35 |
|
| 1996 |
Kos FJ, Engleman EG. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cellular Immunology. 173: 1-6. PMID 8871595 DOI: 10.1006/cimm.1996.0245 |
0.336 |
|
| 1996 |
Weinberg AD, Bourdette DN, Sullivan TJ, Lemon M, Wallin JJ, Maziarz R, Davey M, Palida F, Godfrey W, Engleman E, Fulton RJ, Offner H, Vandenbark AA. Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis Nature Medicine. 2: 183-189. PMID 8574963 DOI: 10.1038/Nm0296-183 |
0.459 |
|
| 1995 |
Takamizawa M, Fagnoni F, Mehta-Damani A, Rivas A, Engleman EG. Cellular and molecular basis of human gamma delta T cell activation. Role of accessory molecules in alloactivation. The Journal of Clinical Investigation. 95: 296-303. PMID 7814628 DOI: 10.1172/JCI117654 |
0.371 |
|
| 1995 |
Mehta-Damani A, Markowicz S, Engleman EG. Generation of antigen-specific CD4+ T cell lines from naive precursors. European Journal of Immunology. 25: 1206-11. PMID 7774624 DOI: 10.1002/eji.1830250511 |
0.404 |
|
| 1995 |
Kapp JA, Pierce CW, Webb DR, Devens B, Godfrey W, Fukuse S, Engleman E, Lake JP, Magnani JI, Maiti PK. Characterization of the epitope recognized by a mAb that reacts differentially with murine suppressor T cells. International Immunology. 7: 1319-30. PMID 7495739 DOI: 10.1093/Intimm/7.8.1319 |
0.42 |
|
| 1994 |
Godfrey WR, Fagnoni FF, Harara MA, Buck D, Engleman EG. Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. The Journal of Experimental Medicine. 180: 757-62. PMID 7913952 DOI: 10.1084/jem.180.2.757 |
0.347 |
|
| 1991 |
Ruegg CL, Engleman EG. Impaired immunity in AIDS. The mechanisms responsible and their potential reversal by antiviral therapy. Annals of the New York Academy of Sciences. 616: 307-17. PMID 1981824 DOI: 10.1111/j.1749-6632.1990.tb17851.x |
0.373 |
|
| 1991 |
Suzuki T, Suzuki N, Daynes RA, Engleman EG. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clinical Immunology and Immunopathology. 61: 202-11. PMID 1833106 DOI: 10.1016/S0090-1229(05)80024-8 |
0.35 |
|
| 1991 |
Suzuki N, Suzuki T, Engleman EG. Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells. The Journal of Experimental Medicine. 173: 1451-61. PMID 1709676 DOI: 10.1084/jem.173.6.1451 |
0.314 |
|
| 1990 |
Bender JR, Pardi R, Engleman E. T-cell receptor-negative natural killer cells display antigen-specific cytotoxicity for microvascular endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. 87: 6949-53. PMID 2402485 DOI: 10.1073/Pnas.87.18.6949 |
0.45 |
|
| 1990 |
Markowicz S, Engleman EG. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. The Journal of Clinical Investigation. 85: 955-61. PMID 2179270 DOI: 10.1172/JCI114525 |
0.304 |
|
| 1990 |
Silverman ED, Somma C, Khan MM, Melmon KL, Engleman EG. Abnormal T suppressor cell function in juvenile rheumatoid arthritis. Arthritis and Rheumatism. 33: 205-11. PMID 2154996 DOI: 10.1002/art.1780330208 |
0.384 |
|
| 1990 |
Rausch DM, Hwang KM, Padgett M, Voltz AH, Rivas A, Engleman E, Gaston I, McGrath M, Fraser B, Kalyanaraman VS, Nara PL, Dunlop N, Martin L, Murphey-Corb M, Kibort T, et al. Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro: Implications for the design of small-peptide anti-HIV therapeutic agents Annals of the New York Academy of Sciences. 616: 125-148. PMID 2078014 DOI: 10.1111/J.1749-6632.1990.Tb17834.X |
0.346 |
|
| 1989 |
Khan MM, Fishwild DM, Melmon KL, Coutre S, Engleman EG, Bauer JA. A subset of human rosetted lymphocytes contains previously unidentified histamine. Clinical Immunology and Immunopathology. 52: 147-59. PMID 2736805 DOI: 10.1016/0090-1229(89)90168-2 |
0.31 |
|
| 1989 |
Damle NK, Engleman EG. Antigen-specific suppressor T lymphocytes in man. Clinical Immunology and Immunopathology. 53: S17-24. PMID 2551552 DOI: 10.1016/0090-1229(89)90066-4 |
0.336 |
|
| 1989 |
Lifson JD, Engleman EG. Role of CD4 in normal immunity and HIV infection. Immunological Reviews. 109: 93-117. PMID 2475427 DOI: 10.1111/j.1600-065X.1989.tb00021.x |
0.334 |
|
| 1988 |
Levitt LJ, Reyes GR, Moonka DK, Bensch K, Miller RA, Engleman EG. Human T cell leukemia virus-I-associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T gamma-lymphoproliferative disease. The Journal of Clinical Investigation. 81: 538-48. PMID 2892860 DOI: 10.1172/JCI113352 |
0.344 |
|
| 1987 |
Weiser B, Burger H, Steimer K, Lifson J, Engleman E, Grimson R, Robinson WS. Antibody to human immunodeficiency virus correlates with decreased T helper lymphocytes in asymptomatic individuals. Journal of Medical Virology. 22: 237-44. PMID 2957464 DOI: 10.1002/Jmv.1890220307 |
0.367 |
|
| 1987 |
Kansas GS, Engleman EG. Phenotypic identification of suppressor-effector, suppressor-amplifier and suppressor-inducer T cells of B cell differentiation in man. European Journal of Immunology. 17: 453-7. PMID 2952513 DOI: 10.1002/eji.1830170403 |
0.343 |
|
| 1986 |
Garcia CF, Lifson JD, Engleman EG, Schmidt DM, Warnke RA, Wood GS. The immunohistology of the persistent generalized lymphadenopathy syndrome (PGL). American Journal of Clinical Pathology. 86: 706-15. PMID 3491535 DOI: 10.1093/ajcp/86.6.706 |
0.326 |
|
| 1986 |
Lifson JD, Feinberg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Steimer KS, Engleman EG. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature. 323: 725-8. PMID 3095663 DOI: 10.1038/323725A0 |
0.357 |
|
| 1986 |
Lifson JD, Reyes GR, McGrath MS, Stein BS, Engleman EG. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science (New York, N.Y.). 232: 1123-7. PMID 3010463 DOI: 10.1126/Science.3010463 |
0.46 |
|
| 1986 |
Mohagheghpour N, Damle NK, Takada S, Engleman EG. Generation of antigen receptor-specific suppressor T cell clones in man. The Journal of Experimental Medicine. 164: 950-5. PMID 2943852 DOI: 10.1084/jem.164.3.950 |
0.41 |
|
| 1985 |
Sansoni P, Silverman ED, Khan MM, Melmon KL, Engleman EG. Immunoregulatory T cells in man. Histamine-induced suppressor T cells are derived from a Leu 2+ (T8+) subpopulation distinct from that which gives rise to cytotoxic T cells. The Journal of Clinical Investigation. 75: 650-6. PMID 3156150 DOI: 10.1172/JCI111743 |
0.397 |
|
| 1985 |
Burger H, Weiser B, Robinson WS, Lifson J, Engleman E, Rouzioux C, Brun-Vézinet F, Barré-Sinoussi F, Montagnier L, Chermann JC. Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome. Annals of Internal Medicine. 103: 545-7. PMID 2994532 DOI: 10.7326/0003-4819-103-4-545 |
0.358 |
|
| 1985 |
Khan MM, Sansoni P, Engleman EG, Melmon KL. Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells. The Journal of Clinical Investigation. 75: 1578-83. PMID 2860125 DOI: 10.1172/JCI111863 |
0.366 |
|
| 1985 |
Levitt L, Kipps T, Engleman E, Greenberg P. Human bone marrow and peripheral blood T lymphocyte depletion: efficacy and effects of both T cells and monocytes on growth of hematopoietic progenitors Blood. 65: 663-679. DOI: 10.1182/blood.v65.3.663.663 |
0.318 |
|
| 1984 |
Luft BJ, Kansas G, Engleman EG, Remington JS. Functional and quantitative alterations in T lymphocyte subpopulations in acute toxoplasmosis. The Journal of Infectious Diseases. 150: 761-7. PMID 6238107 DOI: 10.1093/Infdis/150.5.761 |
0.315 |
|
| 1984 |
Yang YH, Grumet FC, Fendly B, Engleman E, Shively JE. Protein A binding assay for the identification of HLA antigens on peripheral blood lymphocytes by monoclonal antibodies: application to HLA B27. Hybridoma. 1: 243-55. PMID 6208127 DOI: 10.1089/Hyb.1.1982.1.243 |
0.342 |
|
| 1984 |
Mohagheghpour N, Benike CJ, Kansas G, Bieber C, Engleman EG. Activation of antigen-specific suppressor T cells in the presence of cyclosporin requires interactions between T cells of inducer and suppressor lineage. The Journal of Clinical Investigation. 72: 2092-100. PMID 6196379 DOI: 10.1172/JCI111174 |
0.404 |
|
| 1983 |
Kotzin BL, Kansas GS, Engleman EG, Hoppe RT, Kaplan HS, Strober S. Changes in T-cell subsets in patients with rheumatoid arthritis treated with total lymphoid irradiation. Clinical Immunology and Immunopathology. 27: 250-60. PMID 6409481 DOI: 10.1016/0090-1229(83)90075-2 |
0.33 |
|
| 1983 |
Damle NK, Engleman EG. Immunoregulatory T cell circuits in man. Alloantigen-primed inducer T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigenic stimulus. The Journal of Experimental Medicine. 158: 159-73. PMID 6223112 DOI: 10.1084/jem.158.1.159 |
0.383 |
|
| 1982 |
Morhenn VB, Benike CJ, Charron DJ, Cox A, Mahrle G, Wood GS, Engleman EG. Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cells. The Journal of Investigative Dermatology. 79: 277-82. PMID 6752290 DOI: 10.1111/1523-1747.ep12500077 |
0.327 |
|
| 1982 |
Gatenby PA, Kotzin BL, Kansas GS, Engleman EG. Immunoglobulin secretion in the human autologous mixed leukocyte reaction. Definition of a suppressor-amplifier circuit using monoclonal antibodies. The Journal of Experimental Medicine. 156: 55-67. PMID 6211500 DOI: 10.1084/jem.156.1.55 |
0.377 |
|
| 1982 |
Benike C, Metzler C, Gatenby P, Evans R, Engleman E. Monoclonal antibody to a helper T-cell marker (Leu-3) blocks HLA-DR dependent T-cell functions Human Immunology. 5: 140-141. DOI: 10.1016/0198-8859(82)90061-1 |
0.425 |
|
| 1981 |
Engleman EG, Warnke R, Fox RI, Dilley J, Benike CJ, Levy R. Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proceedings of the National Academy of Sciences of the United States of America. 78: 1791-5. PMID 7015346 DOI: 10.1073/pnas.78.3.1791 |
0.379 |
|
| 1980 |
Morhenn VB, Benike CJ, Engleman EG. Inhibition of cell mediated immune responses by 8-methoxypsoralen and long-wave ultraviolet light: a possible explanation for the clinical effects of photoactivated psoralen. The Journal of Investigative Dermatology. 75: 249-52. PMID 6967923 DOI: 10.1111/1523-1747.ep12523271 |
0.312 |
|
| 1980 |
Engleman EG, Benike CJ, Hoppe RT, Kaplan HS, Berberich FR. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. The Journal of Clinical Investigation. 66: 149-58. PMID 6447164 DOI: 10.1172/JCI109828 |
0.361 |
|
| 1980 |
Engleman EG, Benike C, Osborne B, Goldsby R. Functional characteristics of human T-cell subpopulations distinguished by a monoclonal antibody. Proceedings of the National Academy of Sciences of the United States of America. 77: 1607-11. PMID 6445560 DOI: 10.1073/Pnas.77.3.1607 |
0.37 |
|
| 1980 |
Charron D, Benike C, Engleman E. Molecular analysis of human T cell HLA-D molecules: Evidence for synthesis by T cells Human Immunology. 1: 251. DOI: 10.1016/0198-8859(80)90028-2 |
0.303 |
|
| 1979 |
Goldsby RA, Osborne BA, Engleman EG. Identification, isolation, and characterization of a human T cell population by a monoclonal antibody Current Microbiology. 3: 141-146. DOI: 10.1007/Bf02601856 |
0.337 |
|
| 1978 |
Engleman EG, McMichael AJ, McDevitt HO. Suppression of the mixed lymphocyte reaction in man by a soluble T-cell factor. Specificity of the factor for both responder and stimulator. The Journal of Experimental Medicine. 147: 1037-43. PMID 148486 DOI: 10.1084/Jem.147.4.1037 |
0.307 |
|
| 1978 |
Engleman EG, McDevitt HO. A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man. The Journal of Clinical Investigation. 61: 828-38. PMID 147885 DOI: 10.1172/Jci108997 |
0.319 |
|
| 1978 |
Engleman EG, McMichael AJ, Batey ME, McDevitt HO. A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression. The Journal of Experimental Medicine. 147: 137-46. PMID 75232 DOI: 10.1084/Jem.147.1.137 |
0.301 |
|
| Show low-probability matches. |